GLMD - Galmed Pharmaceuticals Ltd

Momentum: Bearish

Recent News

Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why - Galmed Pharmaceuticals ( NASDAQ:GLMD )

Benzinga • 11 months, 3 weeks ago • score: 0.21

Galmed Pharmaceuticals Ltd GLMD shares are surging Thursday after the company announced plans to broaden its drug development activities over the next two years. What Happened: Galmed announced that it plans to expand its drug development activities by adding two additional programs.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. The company is headquartered in Tel Aviv, Israel.

52W High

$15.10

52W Low

$1.15

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.55

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.32

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.36

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

1.19%

Institutions (25–75% balanced)

1.42%

Shares Outstanding

5,479,200

Float

5,229,600

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-5.61

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.54%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.0315

-0.0456

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025